- ホーム
- アプリ分析
- Multiple Myeloma Management
- Multiple Myeloma Management Vs. SurvivorNet
Multiple Myeloma Management vs SurvivorNet使用状況と統計
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
We believe far too many people still struggle to find information about treatments that can save their lives. SurvivorNet is closing this gap by creating a deep, video-based educational resource for patients featuring top physicians and researchers around the country. To create patient-focused educational content, the company is working with physicians at leading NCCN-designated cancer centers such as The National Cancer Institute, Dana-Farber, Memorial Sloan Kettering, Stanford, NYU, and M.D. Anderson.
- Apple App ストア
- 無料
- ヘルス & フィットネス
ストアランキング
- -
Multiple Myeloma Management対SurvivorNetランキング比較
と過去28日間の Multiple Myeloma Management ランキング傾向を比較 SurvivorNet
ランキング
ご利用可能なデータがありません
Multiple Myeloma Management 対 SurvivorNet 国の比較によるランキング
と過去28日間の Multiple Myeloma Management ランキング傾向を比較 SurvivorNet
表示できるデータはありません
無料トライアルで任意のサイトと比較する
Multiple Myeloma Management VS.
SurvivorNet
12月 19, 2024